NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.1 CHF | -0.96% |
|
+1.93% | +16.77% |
| 07-15 | Brace for a flurry of speeches from Fed officials |  |
| 07-15 | European companies cut jobs as economy sputters | RE |
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:
- oncology (29.9%);
- immunology (17.2%);
- cardiovascular, renal and metabolic diseases (14.1%);
- neuroscience (8.9%).
The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.
At the end of 2023, Novartis AG had 33 production sites worldwide.
Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
Pharmaceuticals
Calendar
18/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
110.8
USD
Average target price
112.6
USD
Spread / Average Target
+1.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.77% | 228B | |
| +63.05% | 854B | |
| +39.42% | 636B | |
| -4.78% | 361B | |
| +17.52% | 324B | |
| +8.43% | 301B | |
| +14.19% | 247B | |
| +5.81% | 230B | |
| +14.63% | 177B | |
| +1.08% | 164B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis to Close Technical Research Facility in San Diego, California; 100 Jobs Affected
